GynEC®-DX in a BCC Research forecasting report

BCC Research, a leading provider of market research since 1971, mentioned GynEC®-DX in its forecasting report on Therapies and Diagnostics for Uterine Cancer.

This report HLC142A provides an overview of the current and potential global market for uterine cancer, treatments, screening and testing technologies. The report provides comprehensive information on uterine cancer, highlighting treatment guidelines. It identifies and analyzes the key trends driving the global uterine cancer therapeutics and diagnostics market.

See table of contents